Sasaki, E., Asanuma, H., Momose, H., Furuhata, K., Mizukami, T., & Hamaguchi, I. (2021). Nasal alum-adjuvanted vaccine promotes IL-33 release from alveolar epithelial cells that elicits IgA production via type 2 immune responses. Public Library of Science (PLoS).
Cita Chicago Style (17a ed.)Sasaki, Eita, Hideki Asanuma, Haruka Momose, Keiko Furuhata, Takuo Mizukami, y Isao Hamaguchi. Nasal Alum-adjuvanted Vaccine Promotes IL-33 Release from Alveolar Epithelial Cells That Elicits IgA Production via Type 2 Immune Responses. Public Library of Science (PLoS), 2021.
Cita MLA (8a ed.)Sasaki, Eita, et al. Nasal Alum-adjuvanted Vaccine Promotes IL-33 Release from Alveolar Epithelial Cells That Elicits IgA Production via Type 2 Immune Responses. Public Library of Science (PLoS), 2021.